Prostate Cancer Screening in Men With Germline BRCA2 Mutations
NCT02154672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2021-02-09
Summary
The purpose of this study is to determine the incidence of prostate cancer in men with the BRCa2 gene mutation as an independent indicator for prostate cancer screening.
Conditions
Sponsors & Collaborators
-
Yale University
lead OTHER
Principal Investigators
-
Preston Sprenkle, MD · Yale University
Eligibility
- Min Age
- 30 Years
- Max Age
- 90 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2019-11-01
- Completion
- 2019-11-01
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer
NCT05333432 ·Status: WITHDRAWN ·Phase: NA
-
Genetics of Prostate Cancer in Young Patients
NCT06714227 ·Status: COMPLETED
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT05129605 ·Status: RECRUITING
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
NCT05295407 ·Status: RECRUITING
-
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic Evolution
NCT03421015 ·Status: COMPLETED
-
Identify Genes/Pathways Responsible for Progression From Low Risk to Higher Risk Prostate Cancer
NCT03789253 ·Status: RECRUITING
-
Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer
NCT01013129 ·Status: COMPLETED
-
An Exploration of Genetic Testing for Prostate Cancer Susceptibility
NCT00997464 ·Status: UNKNOWN
-
Characterization of Prostate Cancer With 3T MR
NCT00831142 ·Status: ACTIVE_NOT_RECRUITING
-
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
NCT02594202 ·Status: RECRUITING
-
Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors
NCT04340245 ·Status: ACTIVE_NOT_RECRUITING
-
DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy
NCT07265414 ·Status: ACTIVE_NOT_RECRUITING
-
Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients
NCT03156244 ·Status: COMPLETED
-
PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients
NCT05447637 ·Status: COMPLETED
-
Markers for Early Detection of Prostate Cancer
NCT00340717 ·Status: COMPLETED
-
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
NCT00582543 ·Status: COMPLETED ·Phase: NA
-
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
NCT02543905 ·Status: RECRUITING
-
Prostate Screening Study Using MRI in BRCA Carriers
NCT01990521 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers
NCT03585114 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
NCT05948657 ·Status: RECRUITING ·Phase: NA
-
PRISM: Patient Experiences With PET Imaging in Prostate Cancer
NCT06523777 ·Status: RECRUITING
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants
NCT00898274 ·Status: COMPLETED
-
Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer
NCT04702633 ·Status: COMPLETED